rxvantage Archives - McKesson Ventures

Announcing our latest investment led by Spectrum Equity and McKesson Ventures

by McKesson Ventures | Jan 19, 2022 | Media Coverage, Portfolio News

RxVantage recently shared news of its latest investment directed by McKesson Ventures and Spectrum Equity. These two investors will be joining RxVantage’s existing investors, which include Merck Global Health Innovation Fund, Slater Technology Fund, Javelin Venture...

Announcing our latest investment led by Spectrum Equity and McKesson Ventures

Recent Posts